This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lanford, R. E. Articles by Thomas, D. L. Search for Related Content PubMed PubMed Citation Articles by Lanford, R. E. Articles by Thomas, D. L.

Cross-Genotype Immunity to Hepatitis C Virus

Departments of Virology and Immunology,¹ Comparative Medicine, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227,² Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205³

Received 11 July 2003/ Accepted 13 October 2003

Recent studies in humans and chimpanzees suggest that immunity can be induced to diminish the incidence of chronic hepatitis C virus (HCV) infection. However, the immunity that promotes viral recovery is poorly understood, and whether the breadth of this adaptive immunity is sufficient to overcome the substantial intergenotype antigenic diversity represents a final obstacle to demonstrating the feasibility of vaccine development. Here we demonstrate that recovery from a genotype 1 HCV infection protects chimpanzees against infection with representatives of other genotypes that exhibit up to 30% divergence at the amino acid level, including challenges with genotype 4, a mixture of genotypes 2 and 3, and a complex inoculum containing genotypes 1, 2, 3, and 4. In each instance, the level and duration of viremia were markedly reduced in comparison to the primary infection in the same animal. The data indicate that epitopes conserved between genotypes must play an essential role in immunity. The inocula used in the rechallenge studies induced typical primary infection profiles in naïve chimpanzees. Rechallenge infections were associated with rapid increases in the intrahepatic transcripts of interferon-stimulated genes, even in animals exhibiting apparent sterilizing immunity. Protective immunity was often associated with an early increase in gamma interferon transcripts in the liver and increases in intrahepatic transcripts of Mig, a T-cell chemokine that is a gamma interferon response gene. These studies are the first to show that cross-genotype immunity can be induced to HCV, demonstrating the feasibility of developing a vaccine protective against all HCV strains.

This article has been cited by other articles:

• Scheel, T. K. H., Gottwein, J. M., Jensen, T. B., Prentoe, J. C., Hoegh, A. M., Alter, H. J., Eugen-Olsen, J., Bukh, J. (2008). Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc. Natl. Acad. Sci. USA 105: 997-1002 [Abstract] [Full Text]  
• Li, W., Krishnadas, D. K., Kumar, R., Tyrrell, D. L. J., Agrawal, B. (2008). Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine. Int Immunol 20: 89-104 [Abstract] [Full Text]  
• Schulze zur Wiesch, J., Lauer, G. M., Timm, J., Kuntzen, T., Neukamm, M., Berical, A., Jones, A. M., Nolan, B. E., Longworth, S. A., Kasprowicz, V., McMahon, C., Wurcel, A., Lohse, A. W., Lewis-Ximenez, L. L., Chung, R. T., Kim, A. Y., Allen, T. M., Walker, B. D. (2007). Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection. Blood 110: 1559-1569 [Abstract] [Full Text]  
• Vickerman, P, Hickman, M, Judd, A (2007). Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol 36: 396-405 [Abstract] [Full Text]  
• Brown, R. J. P., Tarr, A. W., McClure, C. P., Juttla, V. S., Tagiuri, N., Irving, W. L., Ball, J. K. (2007). Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes. J. Gen. Virol. 88: 458-469 [Abstract] [Full Text]  
• Manigold, T., Shin, E.-C., Mizukoshi, E., Mihalik, K., Murthy, K. K., Rice, C. M., Piccirillo, C. A., Rehermann, B. (2006). Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 107: 4424-4432 [Abstract] [Full Text]  
• Capone, S., Meola, A., Ercole, B. B., Vitelli, A., Pezzanera, M., Ruggeri, L., Davies, M. E., Tafi, R., Santini, C., Luzzago, A., Fu, T.-M., Bett, A., Colloca, S., Cortese, R., Nicosia, A., Folgori, A. (2006). A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques. J. Virol. 80: 1688-1699 [Abstract] [Full Text]  
• Sugimoto, K., Kaplan, D. E., Ikeda, F., Ding, J., Schwartz, J., Nunes, F. A., Alter, H. J., Chang, K.-M. (2005). Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection. J. Virol. 79: 6976-6983 [Abstract] [Full Text]  
• Rehermann, B., Shin, E.-C. (2005). Private aspects of heterologous immunity. J. Exp. Med. 201: 667-670 [Abstract] [Full Text]